🇺🇸 FDA
Patent

US 10155936

Parkin ligase activation methods and compositions

granted A61KA61K31/4196A61K31/519

Quick answer

US patent 10155936 (Parkin ligase activation methods and compositions) held by AN2H DISCOVERY LIMITED expires Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AN2H DISCOVERY LIMITED
Grant date
Tue Dec 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/4196, A61K31/519, A61K38/00, A61P